Clinical Trials for Diffuse Large B Cell Lymphoma Relapsed

Find clinical trials for diffuse large b cell lymphoma relapsed. Discover research opportunities and treatment options in your area.

3 Active Trials Found

Showing 3 trials on this page

Page 1 of 1

A Study to Evaluate the Safety and Clinical Activity of GF- CART01 (CD20/19 CAR T Cell) in Subjects With Relapsed or Refractory B-Cell Hematological Malignancies

NCT ID: NCT06703892

This clinical trial is studying a new treatment called GF-CART01 for patients with certain types of B-cell blood cancers that have not responded to previous treatments. The trial aims to find out h...

Recruiting

Phase: PHASE1 Type: interventional Locations: Taipei, , Taiwan

A Phase Ib Study of VK-2019 in Patients With Relapsed or Refractory EBV+ Diffuse Large B-cell Lymphomas (DLBCL)

NCT ID: NCT06789159

This clinical trial is studying a new treatment called VK-2019 for adults with a type of cancer known as EBV-positive diffuse large B-cell lymphoma (DLBCL) that has either come back after treatment...

Recruiting

Phase: PHASE1 Type: interventional Locations: Philadelphia, Pennsylvania, United States, Philadelphia, Pennsylvania, United States

Immunotherapy in Lymphoma

NCT ID: NCT06796517

This clinical trial is looking at different treatments for patients with certain types of high-grade B-cell lymphoma that have either come back after treatment or have not responded well to earlier...

Recruiting

Type: observational Locations: Seoul, , Korea, Republic Of, Seoul, , Korea, Republic Of

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions